Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04769596 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis
A NA study, sponsored by Neurent Medical.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT04769596 is a NA study that has completed, run by Neurent Medical. The registered enrollment target is 143 participants.
The verdict
NCT04769596, a NA study, has completed, sponsored by Neurent Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
A randomized, sham-controlled, double-blind study of the NEUROMARKTM system as a treatment for chronic rhinitis
Interventions
- DEVICE Sham Device
- DEVICE NEUROMARK™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2023-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04769596
The ClinicalTrials.gov registry entry for NCT04769596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neurent Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Device is the first listed.
NCT04769596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04769596 about?
NCT04769596 is a clinical study titled "Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis". A randomized, sham-controlled, double-blind study of the NEUROMARKTM system as a treatment for chronic rhinitis
What is the current status of trial NCT04769596?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2021-02-23. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT04769596?
The interventions under investigation include: Sham Device (DEVICE), NEUROMARK™ System (DEVICE).
Who is sponsoring clinical trial NCT04769596?
This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.